Medicom Consulting

You are here  : Home Services Auditing Simulated ( Mock ) FDA Inspection
Simulated ( Mock ) FDA Inspection Print E-mail

SIMULATED ( MOCK ) FDA QSIT INSPECTION SERVICE DESCRIPTION

We can provide a simulated or mock FDA QSIT inspection at your facility to determine the level of compliance of your quality management system with FDA’s Quality System Regulation 21 CFR Part 820.

This normally requires four (4) days onsite inspecting the adequacy of the sub-systems in the same manner as FDA would, and one (1) day for final report writing. A detailed exit meeting is provided on the afternoon of the fourth day, with our final report generally being provided within five (5) working days after completion of the inspection.


The mock FDA QSIT inspection benefits the company in that it provides personnel with a real experience of how an FDA inspection will take place and our report containing inspection findings will help you improve the adequacy of the sub-systems so that the identified problems do not arise during a real FDA inspection.


Our report will detail all observations of nonconformity found during the inspection, with attribution to the clause of the QS Regulation not complied with, including an evaluation of how individual observations would be viewed by FDA management, and what would likely be the overall conclusion on compliance status.

Many valuable lessons will be learned in how to prepare for and manage an inspection by FDA, ensuring your company reduces the potential for the issuance of damaging FDA Form 483’s and associated Warning Letters that can seriously disrupt business and profitability.

Contact us for for more details

 

Latest News

Regulatory Updates

Two new guidance documents on Clinical Investigation: MEDDEVs 2.73/3 & 2.7/4

14-12-2010

FDA CDER (&CBER & CVM) Guidance for Industry: Process Validation: General Principles and Practices

24-11-2011

FDA CDRH: Medical Device Innovation Initiative

February 2011


 
Our 2010 Success

Although the 2010  economy was a difficult year for many businesses, we can look back with justified pride in our success and draw confidence that we can improve and grow our services to the health care industry in 2011, nationally and internationally.

Here are some brief statistics on our 2010 activities, which are indicative of our ongoing success

  • we provided major services to more than 24 medical device and drug facilities
  • we agreed service contracts with 12 new companies
  • we trained over 250 people in the industry, including Competent Authority personnel
  • we successfully project managed 3 FDA compliance inspections in the UK and China

 
Smithers UK (formally RAPRA) partners with Medicom
Medicom has successfully renewed its contract for 2011 with iSmithers to provide bespoke training for medical device polymer suppliers

 
DS Certificering A/S partners with Medicom
Medicom successfully renews contract for 2011 with DS Certificering A/S to provide public and in-house medical device training courses in Denmark.


Public Training Courses

Ireland

Book now to secure your place on our remaining public training courses in 2012

QS Regulation

11-12 June, Limerick, Ireland

Process Validation

13-14 June, Limerick, Ireland

Process Validation

16-17 October, Ireland

QS Regulation

23-24 October, Limerick, Ireland

United Kingdom

Book now to secure your place on our remaining public training courses in 2012 at Smithers RAPRA, Shawbury, Shropshire, UK.

QS Regulation

3 July,

Process Validation

4 July

Medical Device Design & Development

5 July

Denmark

Book now to secure your place on our remaining public training courses in 2012 at DS Certificering, Copenhagen, Denmark.

Process Validation

Dates to be confirmed soon

Medical Device Design and Development Control

Dates to be confirmed soon

Establishing Compliance With ISO 11135-1:2007 for Validation of Ethylene Oxide Sterilization

Dates to be confirmed soon


Links & Downloads

downloads